Stephenson Harwood acts on Piramal deal after Ashurst corporate hire
Stephenson Harwood corporate partner Andrew Edge has scored his first major deal since moving from Ashurst earlier this year after advising India’s Piramal Healthcare on the $3.7bn (£2.57bn) sale of its pharmaceutical unit to Abbott Laboratories. Baker & McKenzie acted for longstanding client Abbott on the deal, with Chicago M&A partners Pablo Garcia-Moreno and Olivia […]